SCH 727965

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for SCH 727965, covering 2015-02-04 to 2017-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630) [Phase 1]